Literature DB >> 24653826

Granular cell tumor of the orbit.

Hossein Salour1, Mehdi Tavakoli1, Saeed Karimi1, Mozhgan Rezaei Kanavi2, Mohammad Faghihi1.   

Abstract

PURPOSE: To report a case of granular cell tumor as a rare orbital pathology. CASE REPORT: A 50-year-old female presented with a 4-year history of diplopia, right ocular displacement and a firm nontender mass in her right lower lid. Computed tomography (CT) scan of the orbit disclosed a well-defined mass in the right inferior orbit involving the right inferior rectus. Subtotal excision of the mass was performed, and histopathologic and immunohistochemical studies revealed granular cell tumor. Subsequently, the tumor recurred and exenteration was required as multiple sessions of radiotherapy failed to prevent the residual tumor from growing.
CONCLUSION: Granular cell tumor, though very rare in the orbit, should be considered in patients with orbital masses especially in cases with involvement of the inferior rectus muscle. Infiltrative tumors may be impossible to completely resect and can rapidly recur following surgery.

Entities:  

Keywords:  Exenteration; Granular Cell Tumor; Orbit; Radiotherapy

Year:  2013        PMID: 24653826      PMCID: PMC3957045     

Source DB:  PubMed          Journal:  J Ophthalmic Vis Res        ISSN: 2008-322X


INTRODUCTION

Granular cell tumor (GCT), previously referred to as granular cell myoblastoma, is a rare benign soft tissue tumor that may involve the orbit, periocular skin, lacrimal sac, optic nerve, ciliary body, conjunctiva and caruncle, in addition to non-ocular tissues such as the skin, gastrointestinal, respiratory and genital tracts, peripheral nerves, and other organs.1,2 This tumor was first described and denominated in 1926 by Abrikossoff as “myoblastic myoma”.3 Various tissues have been proposed as the origin of GCT including striated muscle, histiocytes, fibrocytes and mesenchymal cells. However, recent ultrastructural and immunohistochemical studies suggest Schwann cells as the probable origin of the tumor.4 Although GCT is often described as a discrete benign mass which is well-delineated from adjacent tissues in the orbit, there are some reports of malignant or infiltrating orbital GCTs.1,5 Herein, we present a case of infiltrating and progressive GCT leading to orbital exenteration.

Case report

A 50-year-old woman presented with a 4-year history of vertical diplopia and painless superior displacement of the right eye. She had no history of ocular discharge or thyroid eye disease. Biopsy of the right orbital mass three years before had yielded a non-specific diagnosis. On admission, best corrected visual acuity (BCVA) was 20/30 and 20/20 in the right and left eyes, respectively; a mild afferent pupillary defect was also noted in the right eye. There was a firm non-tender mass palpable through the right lower lid producing a small amount of proptosis and upward displacement. Exophthalmometric values were 18 mm and 14 mm on the right and left sides, respectively (Fig. 1). A significant reduction in ocular abduction and depression was noted without orbital bruits or pulsation. Slit lamp biomicroscopic examination was unremarkable but funduscopy disclosed right optic disc swelling nasally. Ishihara test revealed red-green color deficiency and visual field testing demonstrated a cecocentral scotoma in the right eye. Intraocular pressure was 15 mmHg bilaterally.
Figure 1

Right lower lid mass together with vertical ocular displacement preoperatively.

Orbital computed tomography (CT) scan showed enlargement of the right inferior rectus muscle which was infiltrated by a muscle-density mass displacing the globe upward; maxillary sinus involvement and bone erosions were not observed (Fig. 2).
Figure 2

A well-defined mass in the right orbit with inferior orbital muscle involvement on computed tomography.

Due to close proximity of the tumor with inferior orbital muscles, a subciliary approach was employed to excise the tumor. Under general anesthesia, the anterior portion of the mass was excised as much as possible and sent in 10% formalin solution for histopathologic evaluation. Complete excision of the mass was not feasible due to infiltration of the tumor within the rectus muscle and other orbital structures. Gross examination revealed a cream-colored to brownish firm mass measuring 20Í16Í12mm. After tissue processing and embedding in paraffin blocks, thin sections were stained with hematoxylin and eosin (H&E) and periodic acid-Schiff (PAS). Microscopic examination disclosed a partially encapsulated mass composed of lobules and cords of polyhedral and spindle-shaped cells with bland nuclei and intracytoplasmic PAS-reactive granules (Figures 3A and 3B); however, mitosis was not a feature. The tumor cells were strongly immunoreactive for S100 in both nuclear and cytoplasmic areas but not for HMB45 and pan-cytokeratin immunostaining (Figures 3C and 3D). These histopathologic features were consistent with GCT.
Figure 3

A, the tumor was composed of cords of polyhedral cells with bland nuclei and prominent intracytoplasmic granules (hematoxylin and eosin stain, ×400); B, note periodic acid-Schiff (PAS)-reactive intracytoplasmic granules (PAS stain, ×400); C, strong reactivity of the tumor cells for S100 immunostaining (×400); D, lack of reactivity for HMB45 immunostaining (×400).

During a six-month postoperative course, BCVA of the right eye decreased gradually and multiple sessions of radiotherapy, summing to 40 Gy in 2 Gy fractions, failed to control the growth of the residual tumor. Eventually vision dropped to no light perception and exenteration of the right orbit was performed to prevent extension of the tumor to the optic canal.

DISCUSSION

Granular cell tumors are uncommon benign soft tissue tumors with the basic histopathologic feature of a granular cytoplasm which may occur anywhere in the body.1 Presence of chorioembryonic antigen as a sign of primitive cell origin, immunoreactivity of tumor cells for both S100 protein and myelin basic protein, and presence of basement membrane material around tumor cells on electron microscopy indicate a modified Schwann cell origin for these lesions.6 Approximately, 3% of GCTs arise in the orbit.7 In a review of 31 cases with orbital and periocular GCT, average age was 40 (range 3 to 74) years with no gender preference but varying duration of signs and symptoms, from weeks to years.4 Our patient was a middle-aged woman with a four year history of diplopia and ocular displacement due to an orbital GCT with typical histopathologic and immunohistochemical features of this tumor. Furthermore, our patient showed evidence of optic nerve compression such as reduced vision, afferent pupillary defect, optic disc swelling and abnormalities in color vision and visual fields. The most common reported location for an orbital GCT is the inferior half of the orbit with extraocular muscle involvement, especially the inferior rectus muscle, as a prominent feature8,9 which was observed in our patient. In a literature review by Ribeiro et al including 40 cases of GCT, ocular dysmotility was present in 79% of patients and the inferior rectus was the most commonly involved muscle with diplopia present in most cases.8 Although orbital GCT is usually described as a circumscribed lesion, there are reports of infiltrating lesions.5 In our patient, the tumor seemed rather localized on orbital CT; however, we encountered a diffuse and infiltrating tumor within the inferior rectus muscle and orbital tissues rendering complete resection of the tumor impossible. Tumor excision is recommended for orbital GCTs. Nevertheless, this might be difficult in cases with close association of the tumor with an extraocular muscle due to possibility of permanent muscle dysfunction. In our patient, the condition continued to progress after the operation leading to optic nerve involvement and visual loss. In addition, radiotherapy was performed for the patient in a standard fashion but was ineffective. There are a few reports in which radiotherapy had not proven helpful for the management of GCTs.5,10,11 Eventually, we decided to perform orbital exenteration to prevent intracranial extension of the tumor. The reported local recurrence rate of GCT is about 7%5, however there is no report describing orbital exenteration for management of GCT.5 The current case may demonstrate that an infiltrative GCT which is not completely resectable, may rapidly recur and diffuse within the orbit. In summary, we present a rare case of orbital GCT with progressive growth and rapid recurrence following incomplete excision, eventually necessitating orbital exenteration.
  10 in total

1.  Granular cell tumour of the orbit: radiological findings.

Authors:  I Moseley
Journal:  Neuroradiology       Date:  1991       Impact factor: 2.804

Review 2.  Granular cell tumor: a review of the pathology and histogenesis.

Authors:  N G Ordóñez; B Mackay
Journal:  Ultrastruct Pathol       Date:  1999 Jul-Aug       Impact factor: 1.094

3.  Malignant granular cell myoblastoma: report of a case.

Authors:  G J Kubacz
Journal:  Aust N Z J Surg       Date:  1971-02

4.  Granular cell tumor of the orbit and ocular adnexae.

Authors:  M J Jaeger; W R Green; N R Miller; G J Harris
Journal:  Surv Ophthalmol       Date:  1987 May-Jun       Impact factor: 6.048

5.  Infiltrating orbital granular cell tumour: a case report and literature review.

Authors:  P J Dolman; J Rootman; C L Dolman
Journal:  Br J Ophthalmol       Date:  1987-01       Impact factor: 4.638

6.  Malignant granular cell tumor metastatic to the orbit.

Authors:  S A Callejo; J W Kronish; S J Decker; G R Cohen; R H Rosa
Journal:  Ophthalmology       Date:  2000-03       Impact factor: 12.079

Review 7.  Oculomotor disturbances due to granular cell tumor.

Authors:  Sara F T Ribeiro; Fernando Chahud; Antonio A V Cruz
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2012 Jan-Feb       Impact factor: 1.746

8.  Immunohistochemical localization of S-100 protein and peripheral nerve myelin proteins (P2 protein, P0 protein) in granular cell tumors.

Authors:  M Mukai
Journal:  Am J Pathol       Date:  1983-08       Impact factor: 4.307

9.  Granular cell tumor of the orbit: case report and review of the literature.

Authors:  Z A Karcioglu; G L Hemphill; B M Wool
Journal:  Ophthalmic Surg       Date:  1983-02

10.  Granular cell tumor of the inferior rectus muscle.

Authors:  Ceren Erdoğan Poyraz; Hayyam Kiratli; Figen Söylemezoğlu
Journal:  Korean J Ophthalmol       Date:  2009-03-09
  10 in total
  8 in total

Review 1.  Orbital granular cell tumours: clinical and pathologic characteristics of six cases and literature review.

Authors:  X-F Li; J Qian; Y-F Yuan; Y-W Bi; R Zhang
Journal:  Eye (Lond)       Date:  2016-01-08       Impact factor: 3.775

Review 2.  Solitary, multiple, benign, atypical, or malignant: the "Granular Cell Tumor" puzzle.

Authors:  Isidro Machado; Julia Cruz; Javier Lavernia; Antonio Llombart-Bosch
Journal:  Virchows Arch       Date:  2015-12-05       Impact factor: 4.064

3.  Granular Cell Tumor Located in the Bulbar Subconjunctival Space.

Authors:  Eduardo F Marback; Eduardo Studart; Luciano Espinheira Fonseca; Roberto L Marback
Journal:  Ocul Oncol Pathol       Date:  2017-08-23

4.  Surgical Excision of Orbital Progressive Granular Cell Tumour.

Authors:  Demetrio Germanò; Hossein Mostafa Elbadawy; Diego Ponzin; Daniele Ferro; Leonardo Priore
Journal:  Case Rep Ophthalmol Med       Date:  2015-05-18

5.  Computed tomography and magnetic resonance imaging findings of intraorbital granular cell tumor (Abrikossoff's tumor): a case report.

Authors:  Wei-Hsin Yuan; Tai-Chi Lin; Jiing-Feng Lirng; Wan-You Guo; Fu-Pang Chang; Donald Ming-Tak Ho
Journal:  J Med Case Rep       Date:  2016-05-13

6.  Intraorbital Granular Cell Tumor Involving in Medial Rectus and Optic Nerve.

Authors:  Guo-Yuan Yang; Wei-Min He
Journal:  Chin Med J (Engl)       Date:  2017-07-05       Impact factor: 2.628

7.  Aggressive oral granular cell tumor with periorbital involvement: An unusual case.

Authors:  Rajiv Garg; Gunjan Rana; Siddharth Madan; Anita Nangia; Rekha Yadav
Journal:  J Indian Soc Periodontol       Date:  2021-11-01

Review 8.  An update on mesenchymal tumours of the orbit with an emphasis on the value of molecular/cytogenetic testing.

Authors:  F Roberts; E M MacDuff
Journal:  Saudi J Ophthalmol       Date:  2018-03-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.